久久精品在线视频-久久精品在这里-久久精品这里-久久精品这里精品-久久精品这里热有精品-久久精品这里热有精品2015

BioChain Engineering Research System  

for Key Technologies in the Prevention and Control of Chronic Diseases

Engineering R&D drives high-tech innovations, constructing a comprehensive solution for the “Triple E*” approach to chronic diseases.

Based on innovative liquid biopsy technology, BioChain has established a strategic research framework with the aim of developing proprietary methodologies for the early detection, diagnosis, and intervention (hereinafter referred to as “Triple E*”) of  chronic diseases such as cancer, cardiovascular disease, and cerebrovascular disease. Our research center comprises seven medical engineering research laboratories, including Epigenetics, Multi-omics Integration, Transcription, Proteomics, Bioinformatics, Automation, and Material Engineering laboratories. These laboratories provide guidance and assistance in applying and transforming clinical outcomes.

Proprietary Technologies

Sample Processing Technology

BioChain has developed the industry's first automated equipment for nucleic acid extraction and purification. It includes cell lysis, nucleic acid extraction and purification, and bisulfite conversion on a single automated platform. It can significantly reduces the testing time by 60% when compared to manual operation.

Liquid Biopsy Technology

BioChain offers a wide range of proprietary cfDNA extraction and laboratory preparation kits. Our cfDNA extraction kit can be used with various sample types, such as blood, plasma, and urine. It also delivers 20% higher extraction purity and efficiency compared to high-quality products in the market. Our laboratory preparation kit also uses a single-stranded cfDNA laboratory preparation method for methylation sequencing. Its optimal sequencing depth is 77% higher than other industry-leading products when the same amount of cfDNA is used.

Biomarker Discovery Technology

BioChain primarily integrates Whole Genome Bisulfite Sequencing (WGMS) and Next Generation Sequencing (NGS) methylation-specific panels to ensure sufficient sequencing coverage of cancer-related genes and to distinguish genome-wide methylation levels. A high-efficiency biomarker discovery procedure is achieved when it is combined with self-developed AI interpretation and standardized validation systems.

Pan-Cancer Early Detection

Our current service for the six high-risk cancers in China (lung, colorectal, gastric, esophageal, liver, and thyroid cancers) requires only 10 mL of peripheral blood and has an overall sensitivity, specificity, and tumor tissue-of-origin agreement rate of up to 91.0%, 95.3%, and 85.9%, respectively.(Data as of July 2023)

Artificial Intelligence (AI) Interpretation Technology

BioChain has built a high-performance computing (HPC) cluster with a computing capacity of over 200 trillion operations per second. Combined with its algorithm system, it can seamlessly execute quality control, sequence alignment, feature extraction, and other processes of high-throughput sequencing data, and build multi-dimensional comprehensive models. At present, BioChain has obtained more than ten exclusive algorithm patents related with the Multidimensional and Omics Data Integration Algorithm (MODE).

Industrialization Platform

BioChain has established an advanced industrialization platform and adheres strictly to the ISO13485 Quality Management System. With this approach, the company effectively executes all process stages, including project approval, product development, performance validation, production transfer, preclinical research, registration testing, clinical trials, registration declaration, and marketing authorization. In addition, BioChain operates an industrialization base covering almost 40,000 square meters in the Beijing Economic-Technological Development Area (BDA), enabling it to provide testing products and services to millions of individuals annually.

BioChain Pipeline

As a leader in the “Triple E*” approach to tackling chronic diseases,  BioChain started with a strong focus on gastrointestinal (GI) cancers and has now gradually expanded into dozens of other cancers, as well as other major diseases such as cardiovascular and cerebrovascular diseases.

主站蜘蛛池模板: 久久久免费视频观看 | 97精品伊人 | 天天看片日日夜夜 | 国产丶欧美丶日韩丶不卡影视 | 色综合久久六月婷婷中文字幕 | 亚洲视频日韩 | 毛片段 | 婷婷色中文字幕 | 夜夜夜爽爽爽久久久 | 亚洲国产欧美在线人成 | 四虎国产精品免费久久久 | 日本一级毛片视频网站 | 国产亚洲欧美日韩v在线 | 在线成人欧美 | 久久久久香蕉视频 | 免费国产一区 | 99re6这里有精品热视频在线 | 奇米视频888 | 欧美vs日韩vs国产在线观看 | 日日摸夜夜添夜夜添人人爽 | 欧美成人免费公开播放 | 欧美日本高清动作片www网站 | 99热在线只有精品 | 国产日韩久久久精品影院首页 | 福利视频欧美一区二区三区 | 狠狠2020 | www.久久艹 | 日本aa在线观看 | 四虎a级欧美在线观看 | 香蕉久久网站 | 高清不卡日本v在线二区 | 老湿机午夜影院 | 在线视频综合视频免费观看 | 国产欧美另类久久精品91 | 亚洲美女在线播放 | 99久久国产综合精品女不卡 | 亚洲欧美日韩一级特黄在线 | 欧美日韩在线观看免费 | 一区二区中文字幕在线观看 | 中文字幕日韩欧美一区二区三区 | 精品久久久久久中文字幕女 |